SEC Form D · Amendment · filed February 22, 2024
OcuTerra Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
David J. Tanzer · Boston, MAExecBruce H. Failing · Boston, MADirectorBrenton S. Saunders · Boston, MADirectorWilliam S. Steinkrauss · Boston, MAExecD. S. Edwards · Boston, MAExecBarbara H. Ryan · Boston, MADirectorRobert H. Ruffolo · Boston, MADirectorRobin H. Steele · Boston, MADirectorKerrie Brady · Boston, MAExec · DirectorWilliam H. Koster · Boston, MADirectorD. S. Edwards · Boston, MAExecBrenton S. Saunders · Boston, MADirectorRobin H. Steele · Boston, MADirectorRobert H. Ruffolo · Boston, MADirectorDavid J. Tanzer · Boston, MAExecKerrie Brady · Boston, MAExec · DirectorBarbara H. Ryan · Boston, MADirectorBruce H. Failing · Boston, MADirectorWilliam H. Koster · Boston, MADirectorWilliam S. Steinkrauss · Boston, MAExecManager of the Issuer Seven Hills Capital, LLC · Nashville, TNExecCristie Kerr · Napa, CADirectorErik Stevens · Napa, CAExecCraig F. Farber · New York, NYExecMatthew Joslin · Laguna Beach, CAExec · DirectorDavid West · Bethlehem, PADirectorNick Dicarlo · Bethlehem, PADirectorNickolay E. Bochilo · Greensboro, NCDirectorCindy E. Clare · Greensboro, NCDirectorE. D. Bell · Greensboro, NCDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗